skip to content

Engineering Biology in Cambridge


The Cambridge Academy of Therapeutic Sciences (CATS) would like to announce the opening of the 2023 DCF call. Funding of up to £50,000 (100% direct costs only) for a maximum duration of nine months is available to support early stage translational research from discovery science into new therapies (including repurposing of existing therapies), diagnostics and medical devices.


All Principal Investigators with an affiliation with University of Cambridge are eligible to apply and we encourage early career researchers to apply as co-applicants. This funding is intended to support the generation of initial evidence of efficacy and proof of concept data, prior to seeking substantive downstream funding. If interested, please contact Caroline Reynolds or Juraj Rievaj to discuss your project plans. The deadline for completed applications is Friday 24 March.